1. Four-year results of the AIDA trial: comparison of Absorb bioresorbable scaffold with Xience everolimus-eluting metallic stent in daily clinical practice. (25th November 2020) Authors: Kerkmeijer, L.S.M; Tijssen, R.Y.G; Kraak, R.P; Hofma, S.H; Arkenbout, E.K; Van Der Schaaf, R.J; Weevers, A.P.J; Tijssen, J.G.P; Piek, J.J; Henriques, J.P.S; De Winter, R.J; Wykrzykowska, J.J Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Impact of diabetes mellitus on 2-year outcomes of Absorb BVS compared to Xience EES: a pooled analysis of the COMPARE-ABSORB and AIDA trial. (25th November 2020) Authors: Gao, C; Kerkmeijer, L; Tijssen, R.Y.G; Kraak, R; Tijssen, J; Onuma, Y; Chevalier, B; West, N; Morice, M.C; De Winter, R; Smits, P; Wykrzykowska, J.J; Van Geuns, R.J Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗